Balyasny Asset Management »

Day One Biopharmaceuticals I shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $228k 16k 14.60
2022-12-31 $213k 9.9k 21.52

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Select Sector Spdr Tr Financial (XLF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Hess Put Option (HES)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
JPMorgan Chase & Co. Call Option (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Union Pacific Corporation Call Option (UNP)
Select Sector Spdr Tr Technology (XLK)
Boeing Company (BA)
Deere & Company (DE)

View all positions for Balyasny Asset Management

Top funds holding Day One Biopharmaceuticals I

RA Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Franklin Resources
Braidwell
Viking Global Investors
T. Rowe Price Associates
Goldman Sachs Group
Deerfield Management Company
First Turn Management
Henderson Group
TimesSquare Capital Management
Partner Fund Management
Boxer Capital
Baker Bros. Advisors

View all funds holding Day One Biopharmaceuticals I